Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-008686
Filing Date
2014-05-16
Accepted
2014-05-16 18:09:07
Documents
2
Period of Report
2014-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 5661
2 POWER OF ATTORNEY ex24guerin.txt EX-24.POA 3713
  Complete submission text file 0001179110-14-008686.txt   10868
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
Guerin Mark Patrick (Reporting) CIK: 0001607714 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 14852778